Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy
- 1 November 2001
- journal article
- case report
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 132 (5), 659-667
- https://doi.org/10.1016/s0002-9394(01)01198-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular DegenerationSurvey of Ophthalmology, 2000
- Users' Guides to the Medical LiteratureJAMA, 2000
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- Intravenous Infusion of Liposomal Benzoporphyrin Derivative for Photodynamic Therapy of Experimental Choroidal NeovascularizationAmerican Journal of Ophthalmology, 1996
- Liposomal Benzoporphyrin Derivative Verteporfin Photodynamic TherapyOphthalmology, 1996
- Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered BenzoporphyrinAmerican Journal of Ophthalmology, 1995